Comparison of the Incidence and Pattern of Interstitial Lung Disease During Erlotinib and Gefitinib Treatment in Japanese Patients with Non-small Cell Lung Cancer: The Okayama Lung Cancer Study Group Experience

References

Page 1

	Year	Citations
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu, New England Journal of Medicine	2005	5.4K
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Edward S. Kim, Vera Hirsh, Tony Mok, The Lancet Non-small-cell Lung CancerMedicineMetronomic TherapyClinical TrialsBronchial Neoplasm	2008	1.2K
Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer Román Pérez-Soler, Abraham Chachoua, Lisa A. Hammond, Journal of Clinical Oncology	2004	1.1K
Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies Manuel Hidalgo, Lillian L. Siu, John Nemunaitis, Journal of Clinical Oncology	2001	997
Interstitial Lung Disease in Japanese Patients with Lung Cancer Shoji Kudoh, Harubumi Kato, Yutaka Nishiwaki, American Journal of Respiratory and Critical Care Medicine	2008	481
Severe acute interstitial pneumonia and gefitinib Akira Inoue, Yasuo Saijo, Makoto Maemondo, The Lancet AntibioticsAcute CareInterstitial PneumoniaPulmonary MedicineAcute Medicine	2003	452
Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib Masahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto, Journal of Clinical Oncology	2006	356
Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics David R. Gandara, Tomoya Kawaguchi, John Crowley, Journal of Clinical Oncology	2009	213
Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib Toshimi Takano, Yuichiro Ohe, Masahiko Kusumoto, Lung Cancer Tumor ResponseMedicineCancer ManagementPathologyCancer Treatment	2004	180
Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status Glenwood Goss, David Ferry, Rafal Wierzbicki, Journal of Clinical Oncology	2009	116

Page 1